These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15196301)

  • 21. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naratriptan.
    Salonen R
    Int J Clin Pract; 1999; 53(7):552-6. PubMed ID: 10692743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Meta-analysis of triptan treatment in migraine].
    Nakashima K; Takeshima T; Kowa H
    No To Shinkei; 2004 Sep; 56(9):747-52. PubMed ID: 15552863
    [No Abstract]   [Full Text] [Related]  

  • 24. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational migraine management: optimising treatment with the triptans.
    Millson DS
    Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Deleu D; Hanssens Y
    Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan.
    Al-Shekhlee A; Reed R
    Neurology; 2000 Sep; 55(5):735-6. PubMed ID: 11041768
    [No Abstract]   [Full Text] [Related]  

  • 28. Tolerability of sumatriptan: clinical trials and post-marketing experience.
    Welch KM; Mathew NT; Stone P; Rosamond W; Saiers J; Gutterman D
    Cephalalgia; 2000 Oct; 20(8):687-95. PubMed ID: 11167896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Improved pharmacokinetics. Fast tryptan with sustained response].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():106-7. PubMed ID: 14579498
    [No Abstract]   [Full Text] [Related]  

  • 32. [Highly selective beginning. Associated symptoms and side effects in retrospect].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():107. PubMed ID: 14579499
    [No Abstract]   [Full Text] [Related]  

  • 33. Electriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan.
    Spierings EL
    Neurology; 2000 Sep; 55(5):735; author reply 736. PubMed ID: 10980753
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of acute migraine attacks.
    Weintraub JR
    J Am Osteopath Assoc; 2000 Sep; 100(9 Suppl):S1-7. PubMed ID: 11070658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.
    Yusuf A; Chia V; Xue F; Mikol DD; Bollinger L; Cangialose C
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1309-1315. PubMed ID: 30240072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost savings in migraine associated with less chest pain on new triptan therapy.
    Wang JT; Barr CE; Torigoe Y; Wang E; Rowland CR; Goldfarb SD
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S102-7. PubMed ID: 11859905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
    Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Musing on Mathew et al.
    Kaniecki RG
    Headache; 2003 Sep; 43(8):922; author reply 924-8. PubMed ID: 14562838
    [No Abstract]   [Full Text] [Related]  

  • 40. Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms.
    Mannix LK; Adelman JU; Goldfarb SD; Von S; Kozma CM
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S94-101. PubMed ID: 11859910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.